3005

SHZ:300562

Guangdong Transtek Medical Electronics Co., Ltd

  • Stock

CNY

Last Close

10.83

25/09 07:04

Market Cap

1.87B

Beta: 0.26

Volume Today

51.84M

Avg: 6.26M

PE Ratio

−53.38

PFCF: 41.20

Dividend Yield

0.14%

Payout:−23.31%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
32.72M
-
34.57M
5.64%
35.02M
1.32%
57.83M
65.12%
78.53M
35.80%
84.40M
7.47%
90.29M
6.98%
159.63M
76.79%
217.42M
36.21%
160.01M
26.40%
98.92M
38.18%
average payables
60.43M
-
67.62M
11.90%
71.56M
5.82%
87.66M
22.51%
126.55M
44.36%
210.63M
66.44%
293.50M
39.34%
449.34M
53.10%
561.76M
25.02%
402.47M
28.35%
257.92M
35.92%
average receivables
57.49M
-
61.68M
7.29%
77.87M
26.26%
99.11M
27.27%
131.93M
33.12%
175.67M
33.15%
205.51M
16.99%
266.82M
29.83%
371.54M
39.25%
320.75M
13.67%
220.57M
31.23%
book value per share
0.91
-
1.38
51.10%
1.59
15.63%
3.46
116.83%
2.58
25.28%
2.87
11.25%
2.93
1.83%
3.45
17.77%
4.76
38.04%
4.70
1.19%
capex per share
-0.27
-
-0.14
49.38%
-0.24
75.39%
-0.40
66.12%
-0.40
1.05%
-0.13
66.34%
-0.16
21.49%
-0.52
220.33%
-0.31
41.62%
-0.10
68.03%
capex to depreciation
-13.35
-
-6.68
49.95%
-7.94
18.76%
-10.05
26.67%
-8.41
16.34%
-2.03
75.89%
-2.26
11.48%
-6.75
198.69%
-2.80
58.51%
-0.69
75.43%
-0.45
35.19%
capex to operating cash flow
-0.97
-
-0.34
64.67%
-0.93
172.29%
-0.74
20.58%
19.31
2,706.79%
-0.29
101.51%
-0.42
45.05%
-1.27
200.70%
76.95
6,144.26%
-0.25
100.32%
-0.17
30.03%
capex to revenue
-0.09
-
-0.04
56.78%
-0.05
30.79%
-0.08
40.90%
-0.09
21.68%
-0.03
64.93%
-0.04
11.99%
-0.07
106.82%
-0.04
49.89%
-0.02
46.93%
-0.01
26.18%
cash per share
0.32
-
0.74
129.04%
0.64
13.17%
2.19
241.20%
0.76
65.32%
1.61
112.12%
1.63
1.70%
1.73
5.51%
2.42
40.27%
3.04
25.71%
days of inventory on hand
50.31
-
33.32
33.78%
31.83
4.46%
53.50
68.07%
47.02
12.10%
55.53
18.09%
50.85
8.44%
82.30
61.86%
51.38
37.57%
49.95
2.78%
51.77
3.64%
days payables outstanding
90.14
-
72.34
19.75%
61.98
14.31%
68.88
11.13%
89.93
30.56%
168.78
87.68%
175.35
3.90%
210.18
19.86%
134.42
36.04%
116.16
13.59%
153.72
32.34%
days sales outstanding
56.79
-
51.34
9.61%
53.19
3.60%
50.47
5.10%
66.25
31.27%
91.38
37.92%
89.62
1.92%
86.47
3.52%
85.47
1.15%
73.70
13.77%
93.31
26.61%
debt to assets
0.00
-
0.04
675.93%
0.02
35.10%
0.03
36.48%
0.03
13.37%
0.02
29.34%
0.09
346.35%
0.09
6.98%
debt to equity
0.01
-
0.06
774.46%
0.04
27.15%
0.06
42.50%
0.06
6.11%
0.04
43.20%
0.14
301.11%
0.13
8.99%
dividend yield
0.00
-
0.00
22.12%
0.01
271.76%
0.00
86.34%
0.00
37.37%
0.00
11.94%
0.00
51.01%
0.00
21.40%
0.01
948.39%
0.00
88.14%
earnings yield
0.04
-
0.05
26.19%
0.05
7.55%
0.02
62.46%
0.00
79.33%
0.01
236.50%
0.01
20.09%
0.02
59.94%
0.00
85.63%
-0.01
643.68%
enterprise value
901.37M
-
863.80M
4.17%
900.79M
4.28%
3.92B
335.01%
4.42B
12.78%
1.54B
65.13%
2.75B
78.38%
3.86B
40.60%
3.25B
15.82%
1.99B
38.69%
-531.50M
126.65%
enterprise value over ebitda
20.42
-
15.19
25.64%
13.29
12.48%
47.43
256.84%
118.73
150.33%
33.24
72.01%
54.75
64.73%
42.76
21.91%
85.24
99.35%
50.45
40.82%
-8.01
115.89%
ev to operating cash flow
24.32
-
15.92
34.53%
25.04
57.29%
50.12
100.14%
-1.08K
2,248.67%
18.10
101.68%
36.67
102.65%
49.55
35.13%
-3.69K
7,553.16%
23.56
100.64%
-7.17
130.42%
ev to sales
2.37
-
1.90
19.91%
1.43
24.45%
5.08
255.06%
5.10
0.29%
1.99
61.02%
3.11
56.46%
2.89
7.06%
1.79
38.21%
1.87
4.83%
-0.60
132.10%
free cash flow per share
0.01
-
0.26
2,989.67%
0.02
93.41%
0.14
705.86%
-0.42
403.79%
0.33
177.64%
0.22
31.80%
-0.11
150.44%
-0.31
175.75%
0.30
195.42%
free cash flow yield
0.00
-
0.04
2,989.67%
0.00
93.41%
0.00
95.96%
-0.02
483.76%
0.03
280.86%
0.01
55.72%
-0.01
134.89%
-0.02
266.49%
0.03
238.34%
graham net net
0.08
-
0.44
488.74%
0.44
1.18%
1.92
338.04%
0.34
82.09%
0.76
119.42%
0.58
22.89%
-0.27
145.59%
0.96
462.45%
1.50
55.86%
graham number
2.32
-
3.21
38.09%
3.58
11.51%
6.54
82.96%
2.29
65.03%
2.90
26.77%
3.25
11.95%
5.36
65.03%
2.07
61.37%
3.98
92.50%
income quality
1.05
-
1.20
13.54%
0.72
40.11%
0.97
35.48%
-0.23
124.20%
3.86
1,744.79%
2.51
35.12%
1.15
54.19%
3.20
178.79%
-2.22
169.32%
2.38
207.05%
intangibles to total assets
0.16
-
0.12
25.30%
0.10
15.13%
0.05
49.64%
0.08
44.21%
0.08
0.64%
0.07
10.40%
0.06
3.35%
0.05
17.71%
0.06
16.42%
0.05
13.29%
interest coverage
267.34
-
8.71
-
25.02
187.43%
65.30
160.98%
23.96
63.30%
191.59
699.45%
0.03
99.98%
-17.01
51,327.86%
8.07
147.46%
interest debt per share
0.00
-
0.09
-
0.15
69.83%
0.12
18.82%
0.18
49.16%
0.22
20.47%
0.18
16.99%
0.68
277.17%
inventory turnover
7.25
-
10.96
51.02%
11.47
4.66%
6.82
40.50%
7.76
13.77%
6.57
15.32%
7.18
9.21%
4.43
38.22%
7.10
60.19%
7.31
2.86%
7.05
3.51%
invested capital
0.01
-
0.06
774.46%
0.04
27.15%
0.06
42.50%
0.06
6.11%
0.04
43.20%
0.14
301.11%
0.13
8.99%
market cap
942.43M
-
962.83M
2.17%
991.01M
2.93%
4.24B
327.35%
4.54B
7.19%
1.82B
60.00%
2.94B
61.87%
4.15B
41.21%
3.65B
12.03%
2.45B
33.03%
net current asset value
56.95M
-
107.81M
89.30%
119.40M
10.75%
354.10M
196.56%
240.25M
32.15%
245.87M
2.34%
223.39M
9.14%
199.69M
10.61%
443.83M
122.26%
436.67M
1.61%
467.05M
6.96%
net debt to ebitda
-0.93
-
-1.74
87.15%
-1.33
23.54%
-3.83
187.87%
-3.23
15.71%
-5.93
83.67%
-3.80
35.96%
-3.17
16.64%
-10.44
229.69%
-11.41
9.26%
-8.01
29.75%
net income per share
0.26
-
0.33
26.19%
0.36
7.55%
0.55
54.39%
0.09
83.64%
0.13
44.44%
0.16
23.08%
0.37
131.25%
0.04
89.19%
-0.15
475.00%
operating cash flow per share
0.28
-
0.40
43.28%
0.26
35.59%
0.53
109.16%
-0.02
103.88%
0.46
2,326.86%
0.39
16.24%
0.41
6.53%
-0.00
100.97%
0.39
9,997.29%
payables turnover
4.05
-
5.05
24.61%
5.89
16.70%
5.30
10.01%
4.06
23.41%
2.16
46.72%
2.08
3.75%
1.74
16.57%
2.72
56.35%
3.14
15.72%
2.37
24.44%
receivables turnover
6.43
-
7.11
10.63%
6.86
3.47%
7.23
5.38%
5.51
23.82%
3.99
27.50%
4.07
1.96%
4.22
3.65%
4.27
1.17%
4.95
15.96%
3.91
21.02%
research and ddevelopement to revenue
0.04
-
0.05
44.59%
0.06
16.30%
0.08
29.03%
0.08
0.93%
0.07
4.62%
0.08
6.79%
0.07
7.09%
0.08
13.43%
0.13
56.97%
0.12
4.71%
return on tangible assets
0.19
-
0.18
7.74%
0.16
7.39%
0.13
21.71%
0.03
80.08%
0.03
15.61%
0.03
14.79%
0.05
59.92%
0.01
90.38%
-0.02
526.26%
0.02
204.86%
revenue per share
2.84
-
3.33
17.12%
4.46
34.10%
5.26
17.90%
4.37
16.95%
4.20
4.02%
4.55
8.48%
7.05
54.88%
8.21
16.51%
4.95
39.77%
roe
0.29
-
0.24
16.49%
0.22
6.99%
0.16
28.80%
0.03
78.10%
0.05
29.83%
0.05
20.87%
0.11
96.35%
0.01
92.17%
-0.03
479.51%
0.03
203.50%
roic
0.26
-
0.22
13.20%
0.18
20.51%
0.14
20.93%
0.02
89.08%
0.04
140.69%
0.05
36.91%
0.10
93.27%
0.00
99.99%
-0.03
458,391.06%
0.03
190.86%
sales general and administrative to revenue
0.01
-
0.02
45.21%
0.01
20.26%
0.01
4.36%
0.01
7.32%
0.01
5.67%
0.01
16.21%
0.01
20.29%
0.01
49.66%
0.02
31.56%
0.03
60.86%
shareholders equity per share
0.91
-
1.38
51.10%
1.59
15.63%
3.46
116.83%
2.58
25.28%
2.87
11.25%
2.93
1.83%
3.45
17.77%
4.76
38.04%
4.70
1.19%
stock based compensation to revenue
tangible asset value
86.28M
-
152.97M
77.29%
189.09M
23.61%
471.48M
149.35%
457.26M
3.02%
466.03M
1.92%
502.04M
7.73%
565.13M
12.57%
951.42M
68.35%
902.44M
5.15%
940.12M
4.18%
tangible book value per share
0.64
-
1.12
73.53%
1.34
20.10%
3.22
139.94%
2.31
28.37%
2.52
9.36%
2.59
2.50%
2.98
15.25%
4.29
43.98%
4.19
2.31%
working capital
57.47M
-
108.29M
88.42%
119.40M
10.26%
357.39M
199.32%
240.39M
32.74%
246.65M
2.61%
226.43M
8.20%
213.95M
5.51%
479.58M
124.15%
483.81M
0.88%
509.88M
5.39%

All numbers in CNY (except ratios and percentages)